Athersys Reports Second Quarter 2023 Financial Results and Business Highlights
16.08.2023 - Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced financial results for the three and six months ended June 30, 2023 and provided a business ...
Source: wallstreet-online.de